HI-CeFSpot: High-throughput Immune Cell FluoroSpot assay

Yogita Jethmalani1, Matthew S Sutton1, Robin Carroll1

  • 1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

PubMed

Insights

A new automated High-throughput Immune Cell FluoroSpot (HI-CeFSpot) assay improves precision and reproducibility for immune cell monitoring. This method enhances drug development, immunotherapy efficacy testing, and vaccine research.

Area of Science:

  • Immunology
  • Biotechnology
  • Assay Development

Background:

  • Immunospot assays like ELISpot and FluoroSpot are sensitive tools for immune cell profiling.
  • FluoroSpot offers multiplexing capabilities with fewer cells and faster readouts than flow cytometry.
  • Manual immunospot assays suffer from operator variability and low resolution.

Purpose of the Study:

  • To develop and validate a High-throughput Immune Cell FluoroSpot (HI-CeFSpot) assay for automated immune cell monitoring.
  • To assess the precision, robustness, and reproducibility of the automated HI-CeFSpot assay.
  • To evaluate the HI-CeFSpot assay's performance using non-human primate immune cells stimulated with various agents.

Main Methods:

  • Adaptation of FluoroSpot assay on a Biomek i7 liquid handler with automated plate washing and an IRIS 2 plate reader.
  • Utilized non-human primate immune cells and screened against multiple stimuli to measure interferon gamma (IFN-γ) release.
  • Evaluated assay performance by testing precision, robustness, and reproducibility across different cell types and densities.

Main Results:

  • The HI-CeFSpot assay demonstrated high precision with <10% intra- and inter-plate variability and <15% inter-assay variability.
  • The automated assay exhibited excellent reproducibility and robustness across multiple samples.
  • Successful screening of immune cell responses to various stimuli was achieved with high throughput.

Conclusions:

  • The developed HI-CeFSpot assay provides a high-throughput, precise, and reproducible platform for immune cell analysis.
  • This automated assay is suitable for clinical trial endpoint testing, drug development, and vaccine research.
  • HI-CeFSpot enables efficient and reliable immune cell monitoring and immunotherapy efficacy testing.

Related Concept Videos